A Trial Comparing Qam With Qpm Dosing in Assisted Reproductive Technologies (ART)

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2012 by Virginia Center for Reproductive Medicine
Sponsor:
Information provided by (Responsible Party):
Fady I. Sharara, M.D, Virginia Center for Reproductive Medicine
ClinicalTrials.gov Identifier:
NCT01139593
First received: June 6, 2010
Last updated: December 27, 2012
Last verified: December 2012

June 6, 2010
December 27, 2012
June 2010
June 2014   (final data collection date for primary outcome measure)
Live birth rate [ Time Frame: 4 years ] [ Designated as safety issue: Yes ]
Same as current
Complete list of historical versions of study NCT01139593 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
A Trial Comparing Qam With Qpm Dosing in Assisted Reproductive Technologies (ART)
A Prospective Randomized Trial Comparing Qam With Qpm Daily Dosing in Assisted Reproductive Technologies

This is a prospective randomized trial comparing the outcome in women undergoing IVF/ICSI when taking their gonadotropin dosage in the morning (am) or evening (pm).

Not Provided
Observational
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample

Infertile women between 21 and 44 years old

Infertility
Not Provided
  • morning dose
    women undergoing IVF/ICSi taking their gonadotropin dose in the am
  • evening dose
    Women undergoing IVF/ICSI taking their gonadotropin in the evening
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
200
June 2014
June 2014   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • women between 21-42 undergoing IVF

Exclusion Criteria:

  • women > 45,
  • women with one ovary,
  • donor egg,
  • surrogacy,
  • FET cycles,
  • uterine problems,
  • large fibroids
Female
21 Years to 42 Years
No
Contact: Fady Sharara, M.D 7034377722 fsharara@vcrmed.com
United States
 
NCT01139593
VCRM 5
Yes
Fady I. Sharara, M.D, Virginia Center for Reproductive Medicine
Virginia Center for Reproductive Medicine
Not Provided
Not Provided
Virginia Center for Reproductive Medicine
December 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP